Tebufenpyrad
Tebufenpyrad can induce mitochondrial dysfunction and oxidative damage. Tebufenpyrad induces dose-dependent cell death on N27 cells, with an EC50 value of 3.98 μM[1].
Product Specifications
CAS Number
[119168-77-3]
UNSPSC
12352005
Hazard Statement
H301, H317, H332, H373, H410
Target
Mitochondrial Metabolism
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/tebufenpyrad.html
Purity
99.08
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=C(Cl)C(CC)=NN1C)NCC2=CC=C(C(C)(C)C)C=C2
Molecular Formula
C18H24ClN3O
Molecular Weight
333.86
Precautions
H301, H317, H332, H373, H410
References & Citations
[1]Adhithiya Charli, et al. Alterations in mitochondrial dynamics induced by tebufenpyrad and pyridaben in a dopaminergic neuronal cell culture model.Neurotoxicology. 2016 Mar; 53: 302–313.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal RAIDD/CRADD Antibody (14G8) [DyLight 755]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
GTR15326062 1 Vial
Lentiviral human LAMB4 shRNA (UAS) - Lentiviral human LAMB4 shRNA (UAS) plasmid
Ask
View Details 
